Find information on thousands of medical conditions and prescription drugs.

Osteoarthritis

Osteoarthritis (OA, also known as degenerative arthritis or degenerative joint disease, and sometimes referred to as "arthrosis" or "osteoarthrosis"), is a condition in which low-grade inflammation results in pain in the joints, caused by wearing of the cartilage that covers and acts as a cushion inside joints. As the bone surfaces become less well protected by cartilage, the patient experiences pain upon weight bearing, including walking and standing. Due to decreased movement because of the pain, regional muscles may atrophy, and ligaments may become more lax. OA is the most common form of arthritis. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
Obesity
Obsessive-compulsive...
Occipital horn syndrome
OCD
Ochronosis
Oculocutaneous albinism,...
Oculopharyngeal muscular...
Odontophobia
Odynophobia
Oikophobia
Olfactophobia
Olivopontocerebellar atrophy
Omenn syndrome
Onchocerciasis
Oncocytoma
Ondine's curse
Opportunistic infections
Oppositional defiant...
Optic atrophy
Optic neuritis
Oral leukoplakia
Ornithosis
Orthostatic intolerance
Osgood-Schlatter disease
Osteitis deformans
Osteoarthritis
Osteochondritis
Osteochondritis dissecans
Osteochondroma
Osteogenesis Imperfecta
Osteomalacia
Osteomyelitis
Osteopetrosis, (generic...
Osteoporosis
Osteosclerosis
Otosclerosis
Otospondylomegaepiphyseal...
Ovarian cancer
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The word is derived from the Greek word "osteo", meaning "of the bone", "arthro", meaning "joint", and "itis", meaning inflammation, although many sufferers have little or no inflammation.

OA affects nearly 21 million people in the United States, accounting for 25% of visits to primary care physicians, and half of all NSAID (Non-Steroidal Anti-Inflammatory Drugs) prescriptions. It is estimated that 80% of the population will have radiographic evidence of OA by age 65, although only 60% of those will be symptomatic (Green 2001). Treatment is with NSAIDs, local glucocorticoid injections, and in severe cases, with joint replacement surgery. There is no cure for OA, as it is impossible for the cartilage to grow back.

Signs and symptoms

The main symptom is chronic pain, causing loss of mobility and often stiffness. "Pain" is generally described as a sharp ache, or a burning sensation in the associated muscles and tendons. OA can cause a crackling noise (called "crepitus") when the affected joint is moved or touched, and patients may experience muscle spasm and contractions in the tendons. Occasionally, the joints may also be filled with fluid. Humid weather increases the pain in many patients.

OA commonly affects the hand, feet, spine, and the large weight-bearing joints, such as the hips and knees, although in theory, any joint in the body can be affected. Progressive degeneration of cartilage, technically known as synovium (joint lining), in the knees can lead to them curving outwards in a condition known as "bow legged". As OA progresses, the affected joints appear larger, are stiff and painful, and usually feel worse, the more they are used throughout the day, thus distinguishing it from rheumatoid arthritis.

In smaller joints, such as at the fingers, hard bony enlargements, called Heberden's nodes and/or Bouchard's nodes, may form, and though they are not necessarily painful, they do limit the movement of the fingers significantly. OA at the toes leads to the formation of bunions, rendering them red or swollen.

Causes of disease

The crucial factor in the development of OA is the wearing out and eventual disappearance of synovium, and later, all cartilage of the affected joints. OA may be divided into two types:

  • Primary OA: This type is caused by ageing. As a person ages, the water content of the cartilage increases, and the protein composition in it degenerates, thus degenerating the cartilage through repetitive use or misuse. Inflammation can also occur, and stimulate new bone outgrowths, called "spurs" (osteophyte), to form around the joints. Sufferers find their every movement so painful and debilitating that it can also affect them emotionally and psychologically.
  • Secondary OA: This type is caused by other diseases or conditions such as:
    • obesity. Obesity puts added weight on the joints, especially the knees.
    • diabetes
    • repeated trauma. Certain sports, such as weightlifting, or even football, put undue pressure on the knee joints.
    • hormonal disorders
    • osteoporosis
    • surgery to the joint structures
    • congenital hip luxation (which is genetically determined)
    • inflammatory diseases (such as Perthes' disease), and all chronic forms of arthritis (e.g. rheumatoid arthritis and gout). In gout, uric acid crystals cause the cartilage to degenerate at a faster pace.
    • People with abnormally-formed joints are more vulnerable to OA, as added stress is specifically placed on the joints whenever they move.
    • Ligamentous deterioration or instability may be a factor.

OA often affects multiple members of the same family, suggesting that there is a hereditary basis for this condition. A number of studies have shown that the there is a greater prevalence of the disease between siblings, and especially twins, indicating a hereditary basis. In the population as a whole up to 60% of OA is thought to be as a result of genetic factors.

Read more at Wikipedia.org


[List your site here Free!]


Hyaluronic acid unproven for osteoarthritis of the knee
From American Family Physician, 11/1/05 by Mark Ebell

Clinical Question: Are intra-articular injections of hyaluronic acid (Synvisc) effective for osteoarthritis of the knee?

Setting: Outpatient (specialty)

Study Design: Meta-analysis (randomized controlled trials)

Synopsis: In a previous meta-analysis (Lo GH, et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA December 17, 2003;290:3115-21), investigators found that the use of intra-articular injections of hyaluronic acid to manage osteoarthritis of the knee was minimally effective at best, while a recent Cochrane Review (Bellamy N, et al. Viscosupplemen-tation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005; (2):CD005321; whose authors received funding from the manufacturer) found these injections to be much more effective. Arrich and colleagues examined the same question but differed from the previous two analyses by examining separate outcomes (i.e., pain at rest, pain during exercise, and function) rather than grouping them together. The current study was sponsored by a national insurance program in Austria.

After a careful literature search, the authors included 22 randomized controlled trials. The study quality was generally poor: only seven used concealed allocation; six presented usable data from an intention-to-treat analysis; 16 had blinded outcome assessment; and only four did all of these aspects correctly. Eight studies with a total of 468 patients reported 10 outcomes for pain at rest at two to six weeks. Six of 10 did not demonstrate any benefit; one poorly designed, industry-sponsored study reported a large benefit for 20 and 40 mg. There was too much heterogeneity to combine studies, and poorer quality trials tended to find a greater benefit. Nine studies with 1,141 patients reported 10 outcomes for pain during exercise. Pooled data at 10 to 14 weeks and at 20 to 30 weeks found a statistically--but probably not clinically--significant benefit. Hyaluronic acid had no significant effect on function at any time. In the previous analysis by Lo and colleagues, 17 of 22 trials were found to be industry sponsored.

Bottom Line: The evidence that intra-articular hyaluronic acid helps patients with knee osteoarthritis is of poor quality. Improvements in pain at rest and pain during exercise are seen in a minority of studies, and those studies are of lower quality than those showing no benefit. There is no evidence of functional improvement. Injections such as this have a potentially powerful placebo effect, so any benefit seen in studies without concealed allocation is likely to represent the placebo effect rather than any effect of the drug. (Level of Evidence: 1a--)

MARK EBELL, M.D., M.S.

Study Reference: Arrich J, et al. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ April 12, 2005;172:1039-43.

Used with permission from Ebell M. Hyaluronic acid unproven for knee osteoarthritis. Accessed online August 22, 2005, at: http://www.InfoPOEMs.com.

COPYRIGHT 2005 American Academy of Family Physicians
COPYRIGHT 2005 Gale Group

Return to Osteoarthritis
Home Contact Resources Exchange Links ebay